Study the clinical, biochemical, genetic and radiological profile of cerebral small vessel disease and to investigate the clinical improvement in ischemic stroke patients by Tinospora cordifolia through blinded randomized control trial

All consecutive acute ischemic stroke, will be recruited for the study. The patient would be randomized in two groups. Both the groups would be receiving standard treatment as per national and international guidelines and one group would receive capsules of Tinospora cordifolia and the other group would receive identical looking capsule and patient would be assessed for functional outcome at 3 months. At each level necessary blinding would be done.